prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |review
Ashish Bhalla cites a study of knowledge, attitude, and practice in 40 residents and faculty members from various departments prescribing ATT in one medical institute in India, and says less than 50% knew what directly observed short-course treatment was, less than 50% knew that the World Health Organization (WHO) has classified tuberculosis patients into broad categories; only 57% could answer that sputum-positive patients belong to category I; 47.5% could correctly categorize tuberculosis lymphadenitis to category III; less than 25% could correctly write the exact drug schedule for category II patients; and only 50% could give the correct dosage of antituberculosis drugs.

WHY BLAME PRIVATE PRACTIONERS? A letter to the editor published in Chest. (2001;119:1288-1289; 2001; American College of Chest Physicians) from Ashish Bhalla